This questionnaire has been issued by the Medicines and Healthcare Products Regulatory Agency, also referred to as ‘the Agency’) on behalf of the Competent Authorities for Medical Devices (CAMD) project. The CAMD network is an umbrella under which the national competent authorities in the EU, and associated parties to the system (European Free Trade Association (EFTA) and Turkey), work to enhance the level of collaborative work in what is a single market for medical devices.
Competent authorities have specific responsibilities for market surveillance and other activity under the terms of the legislation. The governance for the network was changed in 2014 to incorporate an elected executive. The executive was charged with developing better collaboration with the European Commission to improve both strategic planning and the distribution of work across both Commission-led and CAMD-led working groups.
The Dalli plan set out 3 challenges: enhance collaborative working; improve market surveillance; and better communication. Subsequently, the CAMD network has initiated 2 Joint Action projects which are designed to help the member states deliver on these commitments, and develop better mechanisms for working together and sharing workload:
— The 1